MedPath

BGM-0504

Generic Name
BGM-0504

A Study of BGM0504 Evaluating Weight Loss in Overweight or Obese Chinese Subjects

Phase 2
Completed
Conditions
Overweight or Obesity
Interventions
Drug: Placebo
First Posted Date
2025-05-15
Last Posted Date
2025-05-15
Lead Sponsor
BrightGene Bio-Medical Technology Co., Ltd.
Target Recruit Count
120
Registration Number
NCT06973681
Locations
🇨🇳

The Third Xiangya Hospital of Central South University, Changsha, China

A Study of BGM0504 in Healthy Participants and Participants With Impaired Renal Function

Phase 1
Recruiting
Conditions
Type 2 Diabetes Mellitus (T2DM)
Overweight or Obese
Interventions
First Posted Date
2025-04-16
Last Posted Date
2025-04-16
Lead Sponsor
BrightGene Bio-Medical Technology Co., Ltd.
Target Recruit Count
32
Registration Number
NCT06929156
Locations
🇨🇳

The First Affiliated Hospital of Shandong First Medical University (Qianfoshan Hospital, Shandong Province), Jinan City, Shandong, China

A Study of BGM0504 in Overweight or Obese Participants

Phase 1
Recruiting
Conditions
Overweight or Obese
Interventions
First Posted Date
2025-04-09
Last Posted Date
2025-04-09
Lead Sponsor
BrightGene Bio-Medical Technology Co., Ltd.
Target Recruit Count
28
Registration Number
NCT06920056
Locations
🇨🇳

The First Affiliated Hospital of Yunnan University of Traditional Chinese Medicine (Yunnan Provincial Hospital of Traditional Chinese Medicine), Kunming, Yunnan, China

A Study of BGM0504 in Participants With Obesity

Phase 2
Recruiting
Conditions
Obesity
Interventions
First Posted Date
2025-04-04
Last Posted Date
2025-04-04
Lead Sponsor
BrightGene Bio-Medical Technology Co., Ltd.
Target Recruit Count
90
Registration Number
NCT06911203
Locations
🇨🇳

Peking University People's Hospital, Beijing, Beijing, China

© Copyright 2025. All Rights Reserved by MedPath